Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
Per Ljungman(Karolinska University Hospital), Jakob Passweg(University Hospital of Basel), Vanderson Rocha(Fundação Pró-Sangue Hemocentro de São Paulo), Marina Cavazzana(Université Rennes 2), Álvaro Urbano-Ispizúa(University of St.Gallen), Gèrard Socié(Hôpital Saint-Louis), Hermann Einsele(Universitätsklinikum Würzburg), J. Alejandro Madrigal(Royal Free London NHS Foundation Trust), T. Demirer(Ankara University), Dietger Niederwieser(Leipzig University of Applied Sciences), Riccardo Saccardi(Azienda Ospedaliero-Universitaria Careggi), Aloïs Gratwohl, Jane F. Apperley(Hammersmith Hospital), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), H. Schouten, Norbert Schmitz(University Hospital Münster), Giorgio Dini
Cited by 266
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k